[1]
|
Cao, W., Chen, H.D., Yu, Y.W., Li, N. and Chen, W.Q. (2021) Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal (England), 134, 783-791.
https://doi.org/10.1097/CM9.0000000000001474
|
[2]
|
陈蕊, 张俊勇, 赵琪. 炎症标志物与消化系统恶性肿瘤相关性的研究进展[J]. 泰山医学院学报, 2021, 42(4): 317-320.
|
[3]
|
Hanahan, D. and Weinberg, R.A. (2011) Hall-marks of Cancer: The Next Generation. Cell, 144, 646-674.
https://doi.org/10.1016/j.cell.2011.02.013
|
[4]
|
Diakos, C.I., Charles, K.A., McMillan, D.C. and Clarke, S.J. (2014) Cancer-Related Inflammation and Treatment Effectiveness. The Lancet Oncology, 15, e493-e503. https://doi.org/10.1016/S1470-2045(14)70263-3
|
[5]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[6]
|
Han, L.H., Jia, Y.B., Song, Q.X., Wang, J.B., Wang, N.N. and Cheng, Y.F. (2015) Prognostic Significance of Preoperative Lymphocyte-Monocyte Ratio in Patients with Resectable Esophageal Squamous Cell Carcinoma. The Asian Pacific Journal of Cancer Prevention, 16, 2245-2250. https://doi.org/10.7314/APJCP.2015.16.6.2245
|
[7]
|
Halazun, K.J., Hardy, M.A., Rana, A.A., Woodland, D.C., Luyten, E.J., Mahadev, S., Witkowski, P., Siegel, A.B., Brown, R.S. and Emond, J.C. (2009) Negative Impact of Neu-trophil-Lymphocyte Ratio on Outcome after Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery, 250, 141-151.
https://doi.org/10.1097/SLA.0b013e3181a77e59
|
[8]
|
Carr, B.I., Cavallini, A., D’Alessandro, R., Refolo, M.G., Lippolis, C., Mazzocca, A. and Messa, C. (2014) Platelet Extracts Induce Growth, Migration and Invasion in Human Hepatocellular Carcinoma in Vitro. BMC Cancer, 14, Article No. 43. https://doi.org/10.1186/1471-2407-14-43
|
[9]
|
Schlesinger, M. (2018) Role of Platelets and Platelet Receptors in Cancer Metastasis. Journal of Hematology & Oncology, 11, 125. https://doi.org/10.1186/s13045-018-0669-2
|
[10]
|
Sakin, A., Alay, M., Sahin, S., Aydemir, O., Aldemir, M.N., Sa-kin, A. and Kotan, C. (2021) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma. Northern Clinics of Istanbul, 8, 435-442.
|
[11]
|
田界勇, 徐广文, 熊燃, 等. 术前中性粒细胞与淋巴细胞比在食管鳞癌中的预后意义[J]. 中山大学学报(医学科学版), 2021, 42(3): 462-467.
|
[12]
|
陈恒琦, 赫捷. 术前外周血中性粒细胞与淋巴细胞比值在食管鳞状细胞癌预后评估中的价值[J]. 中华肿瘤杂志, 2014, 36(4): 294-297.
|
[13]
|
Hoshino, S., Takeuchi, M., Kawakubo, H., Kobayashi, R., Matsuda, S., Irino, T., Fukuda, K., Nakamura, R. and Kitagawa, Y. (2022) Neutrophil-to-Lymphocyte Ratio Change Predicts Histological Response to and Oncological Outcome of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Esophagus, 19, 426-435.
https://doi.org/10.1007/s10388-021-00901-6
|
[14]
|
Sato, H., Tsubosa, Y. and Kawano, T. (2012) Correlation be-tween the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Advanced Esophageal Cancer. World Journal of Surgery, 36, 617-622. https://doi.org/10.1007/s00268-011-1411-1
|
[15]
|
Mohamed, Z., Pinato, D., Mauri, F., Chen, K., Chang, P.M. and Sharma, R. (2014) Inflammation as a Validated Prognostic Determinant in Carcinoma of Unknown Primary Site. British Journal of Cancer, 110, 208-213.
https://doi.org/10.1038/bjc.2013.683
|
[16]
|
Ishibashi, Y., Tsujimoto, H., Yaguchi, Y., Kishi, Y. and Ueno, H. (2019) Prognostic Significance of Systemic Inflammatory Markers in Esophageal Cancer: Systematic Review and Meta-Analysis. Annals of Gastroenterological Surgery, 4, 56-63. https://doi.org/10.1002/ags3.12294
|
[17]
|
Zhang, X., Gari, A., Li, M., et al. (2022) Combining Serum Inflammation Indexes at Baseline and Post Treatment Could Predict Pathological Ef-ficacy to Anti-PD-1 Combined with Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Journal of Translational Medicine, 20, Article No. 61.
https://doi.org/10.1186/s12967-022-03252-7
|
[18]
|
Carruthers, R., Tho, L., Brown, J., Kakumanu, S., McCartney, E. and McDonald, A. (2012) Systemic Inflammatory Response Is a Predictor of Outcome in Patients Undergoing Preopera-tive Chemoradiation for Locally Advanced Rectal Cancer. Colorectal Disease, 14, e701-e707. https://doi.org/10.1111/j.1463-1318.2012.03147.x
|
[19]
|
Son, H.-J., Park, J.W., Chang, H.J., Kim, D.Y., Kim, B.C., Kim, S.Y., et al. (2013) Preoperative Plasma Hyperfibrinogenemia Is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer. Annals of Surgical Oncology, 20, 2908-2913. https://doi.org/10.1245/s10434-013-2968-8
|
[20]
|
张思思, 袁耒. 术前血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值对食管癌预后的预测价值[J]. 肿瘤防治研究, 2017, 44(12): 811-815.
|
[21]
|
Sanchez-Lara, K., Turcott, J.G., Juarez, E., Guevara, P., Núñez-Valencia, C., Oñate-Ocaña, L.F., et al. (2012) Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response with Quality of Life and Prognosis in Patients with Advanced Non-Small-Cell Lung Cancer: A Prospective Study. Nutrition and Cancer, 64, 526-534. https://doi.org/10.1080/01635581.2012.668744
|
[22]
|
Smith, R.A., Ghaneh, P., Sutton, R., Raraty, M., Campbell, F. and Neoptolemos, J.P. (2008) Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio. Journal of Gastrointestinal Surgery, 12, 1422-1428. https://doi.org/10.1007/s11605-008-0554-3
|
[23]
|
Wang, D.S., Luo, H.Y., Qiu, M.Z., Wang, Z.Q., Zhang, D.S., Wang, F.H., et al. (2012) Comparison of the Prognostic Values of Various Inflammation Based Factors in Patients with Pancreatic Cancer. Medical Oncology, 29, 3092-3100.
https://doi.org/10.1007/s12032-012-0226-8
|
[24]
|
吴佳, 赵涤非. 放疗前中性粒细胞与淋巴细胞比值对食管癌患者预后的评估价值[J]. 实用临床医药杂志, 2018, 22(13): 53-55.
|
[25]
|
Du, X., Dong, J., Yan, K., Wang, X., Shen, W. and Zhu, S. (2022) Novel Nomograms Predicting the Survival of Patients with Nonsurgical Thoracic Esophageal Squamous Cell Carcinoma Treated with IMRT: A Retrospective Analysis. Medicine (Baltimore), 101, e30305. https://doi.org/10.1097/MD.0000000000030305
|
[26]
|
Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C. and Jiang, J. (2016) Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esopha-geal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis. Scientific Reports, 6, Article No. 39482. https://doi.org/10.1038/srep39482
|
[27]
|
Wang, L., Wang, C., Wang, J., Huang, X. and Cheng, Y. (2017) A Novel Systemic Immune-Inflammation Index Predicts Survival and Quality of Life of Patients after Curative Resection for Esophageal Squamous Cell Carcinoma. Journal of Cancer Research and Clinical Oncology, 143, 2077-2086. https://doi.org/10.1007/s00432-017-2451-1
|
[28]
|
Feng, J.F., Chen, S. and Yang, X. (2017) Systemic Im-mune-Inflammation Index (SII) Is a Useful Prognostic Indicator for Patients with Squamous Cell Carcinoma of the Esophagus. Medicine (Baltimore), 96, e5886.
https://doi.org/10.1097/MD.0000000000005886
|
[29]
|
Gao, Y., Guo, W., Cai, S., Zhang, F., Shao, F., Zhang, G., Liu, T., Tan, F., Li, N., Xue, Q., Gao, S. and He, J. (2019) Systemic Immune-Inflammation Index (SII) Is Useful to Pre-dict Survival Outcomes in Patients with Surgically Resected Esophageal Squamous Cell Carcinoma. Journal of Cancer, 10, 3188-3196. https://doi.org/10.7150/jca.30281
|
[30]
|
王彦, 王彦文, 郑智尧, 等. 治疗前系统免疫炎症指数与食管癌患者预后关系的meta分析[J]. 华西医学, 2019, 34(3): 315-321.
|
[31]
|
张春艳, 刘明珠, 侯宁, 等. 系统免疫炎症指数对放化疗老年食管癌患者预后的预测作用[J]. 现代消化及介入诊疗, 2021, 26(3): 314-318.
|
[32]
|
夏小春, 黄灿红, 王玲燕, 等. 系统免疫炎症指数对老年食管癌根治性放疗患者的预后价值[J]. 交通医学, 2021, 35(5): 494-497, 500.
|
[33]
|
赵彦, 沈文斌, 李娟, 等. 食管癌患者放疗前系统免疫炎症指数对长期生存的影响分析[J]. 中华放射医学与防护杂志, 2022, 42(3): 198-203.
|
[34]
|
陈清清, 崔红霞, 田野, 等. SII-N评分模型预测老年食管癌预后的初步探讨[J]. 中华放射肿瘤学杂志, 2020, 29(8): 649-653.
|
[35]
|
Yang, J., Zheng, J., Qiu, J., Zhang, M., Liu, L., Wang, Z., et al. (2023) Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy. Journal of Immunology Research, 2023, Article ID: 4275998.
https://doi.org/10.1155/2023/4275998
|
[36]
|
Meytal, G., Matthew, H., Neha, A., et al. (2021) Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer. Cancers (Basel), 13, Article No. 5772.
https://doi.org/10.3390/cancers13225772
|
[37]
|
Eun, O.S., Min-Gew, C., Jeong-Meen, S., et al. (2019) Prognostic Significance of Perioperative Nutritional Parameters in Patients with Gastric Cancer. Clinical Nutrition, 38, 870-876. https://doi.org/10.1016/j.clnu.2018.02.015
|
[38]
|
Simone, C., Tommaso, C., Elisa, D., et al. (2021) Role of Inflam-matory and Immune-Nutritional Prognostic Markers in Patients Undergoing Surgical Resection for Biliary Tract Cancers. Cancers (Basel), 13, Article No. 3594.
https://doi.org/10.3390/cancers13143594
|
[39]
|
Ken, I., Shugo, M., Aoi, H., et al. (2019) Prognostic Nutritional In-dex after Chemoradiotherapy Was the Strongest Prognostic Predictor among Biological and Conditional Factors in Lo-calized Pancreatic Ductal Adenocarcinoma Patients. Cancers (Basel), 11, Article No. 514. https://doi.org/10.3390/cancers11040514
|
[40]
|
Scarpa, M., Filip, B., Cavallin, F., Alfieri, R., Saadeh, L., Cagol, M. and Castoro, C. (2016) Esophagectomy in Elderly Patients: Which Is the Best Prognostic Score? Diseases of the Esoph-agus, 29, 589-597.
https://doi.org/10.1111/dote.12358
|
[41]
|
徐世斌, 徐美青, 孙效辉, 等. 预后营养指数与食管鳞癌患者术后并发症和远期预后的相关性研究[J]. 中国肿瘤临床, 2018, 45(15): 789-794. https://doi.org/10.3969/j.issn.1000-8179.2018.15.451
|
[42]
|
陈云开. 营养预后指数评估术前营养状态对食管癌术后并发症的预测价值[J]. 临床合理用药杂志, 2020, 13(16): 139-140.
|
[43]
|
Nozoe, T., Kimura, Y., Ishida, M., Saeki, H., Korenaga, D. and Sugimachi, K. (2002) Correlation of Pre-Operative Nutritional Condition with Post-Operative Complications in Surgical Treatment for Oesophageal Carcinoma. European Journal of Surgical Oncolo-gy, 28, 396-400. https://doi.org/10.1053/ejso.2002.1257
|
[44]
|
李美端, 张娟, 杨胜生, 等. 营养预后指数评估术前营养状态对食管癌术后并发症的预测价值[J]. 临床与病理杂志, 2018, 38(6): 1267-1273.
|
[45]
|
Xiao, F.K., Wang, L., Zhang, W.C., Wang, L.D. and Zhao, L.S. (2021) Preoperative Prognostic Nutritional Index Is a Significant Predictor of Survival in Esophageal Squamous Cell Carcinoma Patients. Nutrition and Cancer, 73, 215-220.
https://doi.org/10.1080/01635581.2020.1757129
|
[46]
|
Hirahara, N., Tajima, Y., Fujii, Y., Kaji, S., Yamamoto, T., Hyakudomi, R., et al. (2018) Preoperative Prognostic Nutritional Index Predicts Long-Term Surgical Outcomes in Pa-tients with Esophageal Squamous Cell Carcinoma. World Journal of Surgery, 42, 2199-2208. https://doi.org/10.1007/s00268-017-4437-1
|
[47]
|
Nakatani, M., Migita, K., Matsumoto, S., Wakatsuki, K., Ito, M., Nakade, H., Kunishige, T., Kitano, M. and Kanehiro, H. (2017) Prognostic Significance of the Prognostic Nutritional In-dex in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy. Diseases of the Esophagus, 30, 1-7. https://doi.org/10.1093/dote/dox020
|
[48]
|
Nakatani, M., Migita, K., Matsumoto, S., Wakatsuki, K., Ito, M., Nakade, H., Kunishige, T., Kitano, M. and Sho, M. (2018) Prognostic Significance of the Prognostic Nutritional Index in Patients with Recurrent Esophageal Squamous Cell Carcinoma. Nutrition and Cancer, 70, 467-473. https://doi.org/10.1080/01635581.2018.1445771
|
[49]
|
Dai, Y., Fu, X., Li, T., et al. (2019) Long-Term Impact of Prognostic Nutritional Index in Cervical Esophageal Squamous Cell Carcinoma Patients Undergoing Definitive Radio-therapy. Annals of Translational Medicine, 7, 175.
https://doi.org/10.21037/atm.2019.03.60
|
[50]
|
Wang, J., Yu, B., Ye, Y., Shen, J., Ding, N., Tang, H., et al. (2018) Predictive Value of Nutritional Risk Screening 2002 and Prognostic Nutritional Index for Esophageal Cancer Patients Undergoing Definitive Radiochemotherapy. Nutrition and Cancer, 70, 879-885. https://doi.org/10.1080/01635581.2018.1470656
|
[51]
|
Ye, Y., Xu, Y., Fu, Q., et al. (2019) Enteral Nutrition Sup-port Does Not Improve PNI in Radiotherapy Patients with Locally Advanced Esophageal Cancer. Nutrition and Cancer, 71, 223-229.
https://doi.org/10.1080/01635581.2018.1559939
|